Study of antimicrobial effects of vancomycin loaded PLGA nanoparticles against enterococcus clinical isolates

Drug Research

Volumn 64, Issue 7, 2014, Pages 348-352

  Lotfipour, F ^a,b   Abdollahi, S ^b   Jelvehgari, M ^b   Valizadeh, H ^b   Hassan, M ^c   Milani, M ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

minimum inhibitory concentration; nanoparticle; PLGA; vancomycin

Indexed keywords

NANOPARTICLE; POLYGLACTIN; VANCOMYCIN; ANTIINFECTIVE AGENT; DRUG CARRIER; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DRUG POTENCY; DRUG RELEASE; DRUG SOLUTION; ENCAPSULATION; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; EVAPORATION; HYDROPHILICITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARTICLE SIZE; CHEMISTRY; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; PROCEDURES;

ANTI-INFECTIVE AGENTS; DRUG CARRIERS; ENTEROCOCCUS; LACTIC ACID; MICROBIAL SENSITIVITY TESTS; NANOPARTICLES; POLYGLYCOLIC ACID; VANCOMYCIN;

EID: 84904205825     PISSN: 21949379     EISSN: 21949387     Source Type: Journal    
DOI: 10.1055/s-0033-1358747     Document Type: Article

References (47)

1. Lindblad W. Considerations for Determining if a Natural Product Is an Effective Wound-Healing Agent. Int J Low Extrem Wounds: 2008; 7 75 81 (Pubitemid 351678176)
2. Cohen M. Changing patterns of infectious disease. Nature: 2000; 406 762 767
3. Fleming A. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. Clin Infect. Dis: 1980; 2 129 139
4. Sykes R. Penicillin: from discovery to product. Bull World Health Organ: 2001; 79 778 779 (Pubitemid 32776848)
5. Bosch F., Rosich L. The contributions of Paul Ehrlich to pharmacology: atribute on the occasion of the centenary of his Nobel Prize. Pharmacology: 2008; 82 171 179
6. VanEpps H. René Dubos: unearthing antibiotics. J Exp Med: 2006; 203 259
7. Waksman S. What Is an Antibiotic or an Antibiotic Substance? Mycologia: 1947; 39 565 569
8. Walker C. B. Selected antimicrobial agents: mechanisms of action, side effects and drug interactions. Periodontol 2000. 1996; 10 12 28 (Pubitemid 126502725)
9. Kreuter J. Nanoparticles - a historical perspective. Int J Pharm: 2007; 331 1 10
10. Gold H. S., Moellering R. C. Jr. Antimicrobial-drug resistance. N Engl J Med: 1996; 335 1445 1453
11. Walsh C. Molecular mechanisms that confer antibacterial drug resistance. Nature: 2000; 406 775 781
12. FDA antimicrobial agent. available from: http://www.fda.gov/AboutFDA/ Transparency/track/ucm252974.htm: 2011
13. Díez S., Tros de Ilarduya C. Versatility of biodegradable poly(d,l-lactic-co-glycolic acid) microspheres for plasmid DNA delivery. Eur J Pharm Biopharm: 2006; 63 188 197 (Pubitemid 43776215)
14. Zhang L., Gu F. X., Chan J. M. et al. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther: 2008; 83 761 769 (Pubitemid 351556021)
15. Peer D., Karp J. M., Hong S. et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol: 2007; 2 751 760 (Pubitemid 350223348)
16. Heller J. Controlled release of biologically active compounds from bioerodible polymers. Biomaterials: 1980; 1 51 57 (Pubitemid 10061159)
17. Cheng Y. H., Illum L., Davis S. S. A poly(D,L-lactide-co-glycolide) microsphere depot system for delivery of haloperidol. J Control Release: 1998; 55 203 212 (Pubitemid 28477611)
18. Onaizi S. A., Leong S. S. Tethering antimicrobial peptides: Current status and potential challenges. Biotechnology Advances: 2011; 29 67 74
19. Takemoto K., Yamamoto Y., Ueda Y. et al. Comparative studies on the efficacy of AmBisome and Fungizone in a mouse model of disseminated aspergillosis. J Antimicrob Chemother: 2004; 53 311 317 (Pubitemid 38239967)
20. Barrera D. A., Zylstra E., Lansbury P. T. et al. Synthesis and RGD peptide modification of a new biodegradable copolymer: Poly(lactic acid-co-lysine). J Am Chem Soc: 1993; 115 11010 11011
21. Jain R. A. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials: 2000; 21 2475 2490
22. Mohammadi G., Valizadeh H., Barzegar-Jalali M. et al. Development of azithromycin-PLGA nanoparticles: physicochemical characterization and antibacterial effect against Salmonella typhi. Colloid Surface B: 2010; 80 34 39
23. Zhang L., Pornpattananangku D., Hu C. M. et al. Development of Nanoparticles for Antimicrobial Drug Delivery. Curr Med Chem: 2010; 17 585 594
24. Mbela TK M., Poupaert J. H., Dumont P. et al. Development of poly (dialkyl methylidenemalonate) nanoparticles as drug carriers. Int J Pharm: 1993; 92 71 79 (Pubitemid 23159838)
25. Hindi K. M., Ditto A. J., Panzner M. J. et al. The antimicrobial efficacy of sustained release silver - carbene complex-loaded L-tyrosine polyphosphate nanoparticles: Characterization, in vitro and in vivo studies. Biomaterials: 2009; 30 3771 3779
26. Abdollahi S., Lotfipour F. PLGA- and PLA-Based Polymeric Nanoparticles for Antimicrobial Drug Delivery. Biomedicine International: 2012; 3 1 11
27. Fischetti V. A., Novick R., Ferretti J. J. et al. Gram-Positive Pathogens: 2000; 154 162 (American Society for Microbiology Press, Washington, D.C.)
28. Fisher K., Phillips C. The ecology, epidemiology and virulence of Enterococcus. Microbiology: 2009; 155 1749 1757
29. Franz C. M., Holzapfel W. H., Stiles M. E. Enterococci at the crossroads of food safety? Int J Food Microbiol: 1999; 47 1 24
30. Semedo T., Santos M. A., Lopes M. F. et al. Virulence factors in food, clinical and reference enterococci: a common trait in the genus? Syst. Appl. Microbiol: 2003; 26 13 22 (Pubitemid 36514239)
31. Poeta P., Igrejas G., Costa D. et al. Virulence factors and bacteriocins in faecal enterococci of wild boars. J Basic Microbiol: 2008; 48 385 392
32. Vancomycin Solubility Study Available at: http://www.fda.gov/downloads/ Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm082291.pdf
33. th Ed. Philadelphia Lippincott Williams & Wilkins
34. Loll P. J., Axelsen P. H. The structural biology of molecular recognition by vancomycin. Annual review of biophysics and biomolecular structure: 2000; 29 265 289 (Pubitemid 30599595)
35. Zakeri-Milani P., Loveimi B., Jelvehgari M. et al. The characteristics and improved intestinal permeability of Vancomycin PLGA-nanoparticles as colloidal drug delivery system. Colloids Surf B Biointerfaces: 2013; 103 81 174
36. Facklam R. R., Collins M. D. Identification of Enterococcus Species Isolated from Human Infections by a Conventional Test Scheme. J Clin Microbiol: 1989; 27 731 734
37. th ed ASM Press Washington, D.C., USA: 2003
38. MANERO AB A. Identification of Enterococcus spp. with a Biochemical Key. Appl Environ Microb: 1999; 65 4425 4430
39. The Clinical and Laboratory Standards Institute (CLSI) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard, Wayne, Pennsylvania, USA. Seventh Edition CLSI document M7-A7: 2006
40. Sheikh H. Effect of the microencapsulation of nanoparticles on the reduction of burst release. Int J Pharm: 2007; 344 53 61
41. Dash A. K. Determination of the physical state of drug in microcapsule and microsphere formulations. J Microencapsul: 1997; 14 101 112
42. Sprockel O. L., Prapaitrakul W. A comparison of muencapsulation by various emulsion techniques. Int J Pharm: 1990; 58 123 127 (Pubitemid 20042452)
43. Youan B. B., Jackson T. L., Dickens L. et al. Protein release profiles and morphology of biodegradable microcapsules containing an oily core. J Control Release: 2001; 76 313 326 (Pubitemid 32913439)
44. Hassan M., Diep D. B., Javadzadeh Y. et al. Prevalence of bacteriocin activities and bacteriocin-encoding genes in enterococcal clinical isolates in Iran. Can J Microbiol: 2012; 58 359 368
45. Cheow W. S., Chang M. W., Hadinoto K. Antibacterial Efficacy of Inhalable Levofloxacin-Loaded Polymeric Nanoparticles Against E. coli Biofilm Cells: The Effect of Antibiotic Release Profile. Pharm Res: 2010; 27 1597 1609
46. Alonso M. J., Losa C., Calvo P. et al. Approaches to improve the association of amikacin sulphate to poly(alkylcyanoacrylate) nanoparticles. Int J Pharm: 1991; 68 69 76
47. Abeylath S. C., Turos E., Dickey S. et al. Glyconanobiotics: Novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracis. Bioorgan Med Chem. 2008; 16 2412 2418